Sign in to view content

Pooled Safety Analysis and Immunogenicity of a Single Intravitreal Injection of JNJ-1887 (Gene Therapy, AAVCAGsCD59) in Patients With AMD

Christine Kay, MD

Video
Published 2024

Related

Intravitreal Tarcocimab Tedromer for Diabetic Retinopathy: First-time, Primary Endpoint Results from the Phase 3 GLOW2 Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2026
Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2021
The MOSAIC Study: A Clinical and Humanistic Burden of Illness Study of Patients With GA and Their Caregivers in the United States and Canada
Sophie Jane Bakri, MD
Annual Meeting Talks
2023

Category: AMD-Non-Neovascular

See more